Skip Navigation

A Randomized Open-Label Phase II/III Study of BT8009 as Monotherapy or in Combination in Participants with Locally Advanced or Metastatic Urothelial Cancer Duravelo-2

Brief Summary

Type:
Bladder

Study Type:
Treatment

Phase:
II/III

ClinicalTrials.gov Identifier:
NCT06225596

Study #:
STUDY00160137

Start Date:
Jul 01, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06225596

View Complete Trial Details & Eligibility at ClinicalTrials.gov